Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies.
Glycoproteins isolated from human milk fat globule membranes, designated epithelial membrane antigen (EMA), have been detected immunohistochemically in most nonneoplastic epithelia and are potentially a highly effective marker for establishing the epithelial nature of neoplastic cells. With commercially available monoclonal antibodies and an indirect immunoperoxidase technique, EMA localization was evaluated in paraffin-embedded tissues from a wide variety of neoplasms (320 specimens). Adenocarcinomas from various primary sites (breast, lung, colon, stomach, pancreas, gallbladder, prostate, endocrine glands, ovary, kidney, thyroid) were immunoreactive for EMA in 88 of 97 cases (91 per cent). Cytoplasmic and apical luminal membrane staining were the most common patterns of immunoreactivity, with peripheral membrane staining or other patterns also seen in some neoplasms. Squamous cell (13 of 13 cases) and transitional cell (12 of 12 cases) carcinomas, small cell anaplastic carcinomas (12 of 12 cases), and mesotheliomas (six of six cases) were also uniformly EMA-positive. Malignant lymphomas of the Hodgkin's (15 cases) and non-Hodgkin's types (74 cases), except for the true histiocytic lymphomas and occasional T-cell lymphomas, were nonreactive for EMA. Neoplastic and nonneoplastic plasma cells showed variable EMA positivity. Endocrine neoplasms (17 cases), including carcinoid tumors, medullary carcinoma of thyroid, adrenocortical carcinomas and pheochromocytomas, and germ cell tumors (eight cases, embryonal carcinoma and seminoma), and a wide variety of soft tissue tumors (27 cases) generally lacked immunoreactivity for EMA; the exceptions to this finding were synovial sarcomas and an epithelioid sarcoma. Malignant melanomas (eight cases) were typically nonreactive. Based on the observations in this large series of neoplasms, EMA is an excellent marker of epithelial differentiation, appears to be highly reliable for discriminating between poorly differentiated carcinomas and malignant lymphomas, and is especially helpful in characterizing small cell anaplastic carcinomas. Epithelial membrane antigen immunoreactivity is well preserved in paraffin sections of routinely processed tissues, facilitating application of this technique in diagnostic surgical pathology.
Pinkus
G S
GS
Kurtin
P J
PJ
D000230:Adenocarcinoma / Q000276:immunology; D000911:Antibodies, Monoclonal; D006528:Carcinoma, Hepatocellular / Q000276:immunology; D018288:Carcinoma, Small Cell / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002295:Carcinoma, Transitional Cell / Q000276:immunology; D006651:Histocytochemistry; D006652:Histological Techniques; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007120:Immunochemistry; D008113:Liver Neoplasms; D008565:Membrane Proteins / Q000276:immunology*; D008654:Mesothelioma / Q000276:immunology; D018396:Mucin-1; D009101:Multiple Myeloma / Q000276:immunology; D009369:Neoplasms / Q000175:diagnosis* / Q000276:immunology; D009447:Neuroblastoma / Q000276:immunology; D010145:Paget Disease, Extramammary / Q000276:immunology; D010954:Plasmacytoma / Q000276:immunology; D012468:Salivary Gland Neoplasms / Q000276:immunology; D012509:Sarcoma / Q000276:immunology; D013584:Sarcoma, Synovial / Q000276:immunology; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology
D000911:Antibodies, Monoclonal; D008565:Membrane Proteins; D018396:Mucin-1